Company Filing History:
Years Active: 2021
Title: Nicola Elizabeth Wilsher: Innovator in Pharmaceutical Chemistry
Introduction
Nicola Elizabeth Wilsher is a prominent inventor based in Cheveley, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. Her work exemplifies the intersection of innovation and healthcare.
Latest Patents
Wilsher holds a patent for a compound known as 6-pyrimidin-isoindole derivative, which acts as an ERK1/2 inhibitor. This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide. The patent details novel physical forms of the compound, a process for preparing it, synthetic intermediates for use in the process, and formulations containing the compound, along with its therapeutic uses.
Career Highlights
Wilsher is currently associated with Otsuka Pharmaceutical Company, Limited, where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions that address critical health challenges.
Collaborations
Throughout her career, Wilsher has collaborated with notable colleagues, including Michael Reader and Mark Henry Saunders. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Nicola Elizabeth Wilsher is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. Her patent for the 6-pyrimidin-isoindole derivative showcases her commitment to advancing medical science. Through her work at Otsuka Pharmaceutical Company, Limited, she continues to make a significant impact in the field.